• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".

作者信息

Selvaraj Senthil, Kosiborod Mikhail N, Shah Svati H

机构信息

Duke Molecular Physiology Institute, Durham, NC (S.S., S.H.S.).

Division of Cardiology, Duke University Medical Center, Durham, NC (S.S., S.H.S.).

出版信息

Circulation. 2023 Mar 14;147(11):922-923. doi: 10.1161/CIRCULATIONAHA.122.063395. Epub 2023 Mar 13.

DOI:10.1161/CIRCULATIONAHA.122.063395
PMID:36913500
Abstract
摘要

相似文献

1
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".塞尔瓦拉杰等人对关于文章《达格列净对射血分数降低的心力衰竭的影响的代谢组学分析：DEFINE-HF》的信件的回应
Circulation. 2023 Mar 14;147(11):922-923. doi: 10.1161/CIRCULATIONAHA.122.063395. Epub 2023 Mar 13.
2
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".蒙佐和梅莱诺夫斯基就文章《达格列净对射血分数降低的心力衰竭的影响的代谢组学分析：DEFINE-HF》所写的信函
Circulation. 2023 Mar 14;147(11):920-921. doi: 10.1161/CIRCULATIONAHA.122.061155. Epub 2023 Mar 13.
3
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.达格列净对射血分数降低的心力衰竭患者症状、功能和生活质量的影响：来自 DAPA-HF 试验的结果。
Circulation. 2020 Jan 14;141(2):90-99. doi: 10.1161/CIRCULATIONAHA.119.044138. Epub 2019 Nov 17.
4
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.达格列净在射血分数降低的心力衰竭中的疗效和安全性：来自 DAPA-HF 的见解。
Circulation. 2020 Jan 14;141(2):100-111. doi: 10.1161/CIRCULATIONAHA.119.044133. Epub 2019 Nov 17.
5
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial.达格列净在射血分数降低的心力衰竭男性和女性患者中的疗效和安全性：达格列净和心力衰竭结局预防试验的预先指定分析。
JAMA Cardiol. 2021 Jun 1;6(6):678-689. doi: 10.1001/jamacardio.2021.0379.
6
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.达格列净对射血分数降低的心力衰竭患者生物标志物、症状和功能状态的影响：DEFINE-HF 试验。
Circulation. 2019 Oct 29;140(18):1463-1476. doi: 10.1161/CIRCULATIONAHA.119.042929. Epub 2019 Sep 16.
7
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction.达格列净的临床获益时间和心力衰竭射血分数降低患者既往心力衰竭住院的意义。
JAMA Cardiol. 2021 May 1;6(5):499-507. doi: 10.1001/jamacardio.2020.7585.
8
Evaluation of dapagliflozin in the treatment of heart failure.评价达格列净在心力衰竭治疗中的作用。
Future Cardiol. 2021 May;17(3):415-425. doi: 10.2217/fca-2020-0138. Epub 2020 Oct 5.
9
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.达格列净对射血分数降低的心力衰竭患者肾功能和结局的疗效：DAPA-HF 研究结果。
Circulation. 2021 Jan 26;143(4):298-309. doi: 10.1161/CIRCULATIONAHA.120.050391. Epub 2020 Oct 12.
10
The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure.DAPA-HF 试验：心力衰竭之战的重大胜利。
Cell Metab. 2019 Nov 5;30(5):847-849. doi: 10.1016/j.cmet.2019.10.008.